N ewly recruited polymorphonuclear neutrophils (PMNs) 3 progress through a complex series of functional and phenotypic changes that permit adhesion and extravasation, including L-selectin engagement and shedding during rolling adhesion, activation and enhanced expression of ␤ 2 integrins during firm adhesion, and activation signaling through chemokine receptors (1) . Many of the mechanisms that regulate PMN adhesion and locomotion are also involved in transitioning the cells from quiescence to proinflammatory phenotypes. Activation signals originating with L-selectin and CR3 (CD11b/CD18) can cooperate with chemokine-generated signals to enhance this process (2) (3) (4) (5) . The urokinase plasminogen activator receptor (uPAR; CD87) subserves numerous functions important for leukocyte adhesion and movement. The function originally described for uPAR is to serve as a docking site for urokinase-type plasminogen activator (uPA), allowing it to function as a membrane-stabilized ectoenzyme that facilitates conversion of cell-associated plasminogen to plasmin (6) . Plasmin, in turn, would degrade pericellular matrix proteins, allowing leukocytes to breach tissue barriers and fibrin-rich provisional stroma at inflammatory foci. Subsequently, it has been demonstrated that uPAR serves obligate roles in chemotaxis of monocytes and PMNs in vitro that are unrelated to its capacity to bind uPA (7, 8) . The uPAR can form lateral associations with ␤ 1 , ␤ 2 , ␤ 3 , and ␤ 5 integrins, and in some instances, coupling with uPAR modulates integrin adhesive functions (9 -15) . Numerous studies have also shown that binding uPA to uPAR can initiate activation signaling cascades, raising the possibility that uPAR engagement during leukocyte recruitment also regulates activation signaling (16 -22) . Most studies of uPAR-mediated signaling have used high concentrations of exogenous uPA to engage uPAR and initiate the signaling process. The physiologic counterpart of achieving near-saturation binding of uPAR is not clear, because mononuclear phagocytes and related cell lines express uPAR ϳ50% occupied with uPA, a receptor occupancy rate that does not change appreciably even as in vitro activation up-regulates uPA and uPAR expression (23, 24) . PMNs reportedly express a lower proportion (10 -15%) of occupied receptors, again with little change after in vitro stimulation (25) . One of the signature changes in leukocyte uPAR is that it aggregates at the cell-substratum interface during adhesion and at the leading edge of polarized, migrating cells (7, 26 -28) . We recently demonstrated in promonocyte-like U937 cells and human monocytes that uPAR aggregation, achieved by Ab-mediated cross-linking, stimulates prompt increases in intracellular levels of d-myo-inositol (1, 4, 5) trisphosphate, followed by increases in the intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) that were blocked by 1) depleting intracellular Ca 2ϩ stores with thapsigargin, 2) inhibiting phospholipase C with U73122, and 3) inhibiting tyrosine kinase with herbimycin A, but were less affected by reducing extracellular Ca 2ϩ (27) . From these findings, it was concluded that uPAR aggregation triggers phosphoinositide hydrolysis and mobilization of intracellular Ca 2ϩ , with secondary influxes of extracellular Ca 2ϩ . Recognizing that human PMN express uPAR both on the plasma membrane and in a readily mobilized pool in intracellular granules, we sought in this study to determine whether uPAR aggregation can also initiate activation signaling in human PMN and regulate the proinflammatory phenotype and function of these cells.
Materials and Methods

Reagents
Purified murine IgG Fc fragments and F(abЈ) 2 of goat Ab reactive against murine IgG F(abЈ) 2 were obtained from Jackson ImmunoResearch Laboratories (West Grove, PA). Anti-uPAR mAb (IgG2a; clone 3B10) was purified from mouse ascites by protein A-Sepharose and quantitated by protein content (29) . The 3B10 anti-uPAR mAb recognizes an epitope near the uPA binding site and thus preferentially binds to unoccupied uPAR, as demonstrated by a partial (70%) reduction in 3B10 binding after saturating uPAR with exogenous uPA (30) . High m.w. uPA (HMW-uPA; 90,000 IU/mg protein) was obtained from American Diagnostica (Greenwich, CT). FITC-labeled anti-CD11b mAb, anti-L-selectin mAb, and IgG1 control mAb were obtained from BioSource (Camarillo, CA).
Purification and stimulation of human PMNs
Peripheral blood was obtained from healthy volunteers according to the provisions of the University of Michigan institutional review board for human subject research. PMNs were isolated to Ͼ95% purity by sedimentation in 6% dextran in Ca 2ϩ /Mg 2ϩ -free PBS, followed by hypotonic lysis of RBCs with H 2 O for 30 s and centrifugation through Ficoll-Paque (Amersham Pharmacia Biotech, Piscataway NJ). To cross-link uPAR, cells were suspended in experimental buffer (145 mM NaCl/5 mM KCl/1 mM MgCl 2 /10 mM glucose/1 mM CaCl 2 /1% (w/v) BSA/10 mM HEPES, pH 7.4). Cells were first incubated with murine IgG Fc fragments (150 g/ml) at 4°C for 15 min to block binding of the primary Abs to Fc receptors. Cells were then incubated with the anti-uPAR mAb or a control IgG2a mAb (100 g/ml) at 4°C for 30 min, and washed in experimental buffer at 4°C. To initiate receptor cross-linking, F(abЈ) 2 of goat anti-mouse F(abЈ) 2 Ab (100 g/ml) were added after warming the cells to 37°C. Previous studies have shown by immunofluorescence microscopy that virtually identical protocols for Ab-mediated uPAR cross-linking in human neutrophils produce readily evident receptor capping in approximately one-half of labeled cells (10, 22) . To selectively aggregate uPA/uPAR complexes, cells were blocked with Fc fragments as described above and then treated with an anti-uPA mAb (100 g/ml; 394OA, American Diagnostica) or an IgG1 control, followed by the F(abЈ) 2 of goat anti-mouse F(abЈ) 2 Ab (100 g/ml) as described above. In some instances, available uPAR were preloaded with an excess of HMW-uPA (1 g/ml, ϳ20 nM) for 15 min at 4°C in experimental buffer, washed, and then subjected to cross-linking with the anti-uPA mAb. To confirm that HMW-uPA added in this way binds predominately to uPAR, PMNs were pretreated with a polyclonal rabbit antihuman uPAR Ab or control rabbit IgG, followed by FITC-labeled uPA (1 g/ml for 15 min, 4°C; American Diagnostica). Flow cytometry confirmed that the anti-uPAR Ab inhibited binding of the FITC-uPA by 93 Ϯ 3.7% relative to the control Ab (mean Ϯ SEM; n ϭ 3).
Measurement of [Ca 2ϩ ] i
Cells were loaded (5 ϫ 10 6 /ml) with the Ca 2ϩ -sensitive fluorescent dye fluo-3/AM (2 M; Molecular Probes, Eugene OR) at 30°C for 30 min in 145 mM NaCl/5 mM KCl/1 mM MgCl 2 /10 mM glucose/4 mM probenecid/10 mM HEPES, pH 7.4. After pretreatment with Abs as indicated, 2.5 ϫ 10 6 cells were suspended in 1 ml of incubation buffer and prewarmed to 37°C. Fluorescence intensity was then measured with a SLM8000 spectrofluorometer equipped with SLM Spectrum Processor version 3.5 software (SLM Instruments, Urbana, IL), using a 1-cm light path cuvette with continuous stirring at an excitation wavelength of 505 nm and an emission wavelength of 530 nm. Fluorescence measurements were acquired at 2-s intervals for 300 s and converted to nanomolar concentrations of [Ca 2ϩ ] i by the calibration method of Grynkiewycz et al. (31) , using a K d for fluo-3 of 864 nM (32) .
Immunofluorescence flow cytometry
For immunolabeling, cells were resuspended in labeling buffer (PBS with 0.1% human ␥-globulin and 0.1% glucose, pH 7.4) and incubated with the specified primary mAb for 30 min, 4°C, followed by PE-conjugated goat anti-mouse Ab (30 min, 4°C 
Neutrophil degranulation
␤-Glucuronidase (a marker of azurophilic granules) was measured by incubating conditioned medium 1:4 (v/v) with 10% phenolpthalene ␤-monoglucuronate in 70 mM sodium acetate buffer, pH 4.5, for 18 h at 37°C. The reaction was then stopped with 0.4 M glycine buffer, pH 10.5, and read in a microplate spectrophotometer at 540 nm. The reaction product was standardized against known quantities of phenolpthalene, and release was expressed as a percentage of the total cellular content in excess of unstimulated cells cultured in parallel (33) . Lactoferrin (a marker for specific granules) was assayed by ELISA, using a rabbit anti-human lactoferrin capture IgG and a peroxidase-conjugated rabbit anti-human lactoferrin detection IgG (ICN/Cappel, Costa Mesa, CA), developed with a standard phenylene diamine substrate and standardized to purified human lactoferrin (34, 35) . Data are expressed as nanograms per milliliter released in excess of unstimulated control cells.
Superoxide release
PMNs were incubated in 145 mM NaCl/5 mM KCl/1 mM MgCl 2 /10 mM glucose/1 mM CaCl 2 /1% (w/v) BSA/10 mM HEPES, pH 7.4, with Fe 3ϩ cytochrome c (675 g/ml; Sigma, St. Louis, MO) with or without superoxide dismutase (250 g/ml; Sigma) for 45 min at 37°C. The reaction was terminated by rapid chilling to 4°C and removing the cells by centrifugation. Conditioned medium was then transferred to microtiter wells and read at 550 nm in a plate spectrophotometer. Superoxide production was determined from a standard curve relating absorbances to known quantities of sodium dithionite-reduced Fe 3ϩ cytochrome c, and data are expressed as nanomoles of superoxide released per 45 min/10 6 cells (36) .
Statistical analysis
Individual comparisons of group means were performed with two-tailed Student's t tests, with p Յ 0.05 considered significant. Multiple comparisons were performed using one-way ANOVA, with Dunnett's post-test for multiple comparisons to a single control or Bonferroni's post-test for multiple selected comparisons, as indicated. All analyses were performed with GraphPad Prism version 3.00 for Windows (GraphPad Software, San Diego, CA).
Results
Expression of uPAR by human PMNs
uPAR was demonstrable by flow cytometry on 34 Ϯ 3.6% (mean Ϯ SEM; n ϭ 9) of PMNs immediately after purification, in keeping with prior observations that uPAR is expressed on PMNs at relatively low levels before stimulation with proinflammatory agents (25) . There was significant interdonor variability in the quantity of uPAR expressed, with the sampled population expressing 2.3 Ϯ 1.24 arbitrary units (mean Ϯ SD; coefficient of variation, 54%; range, 0.82-4.3). Flow cytometry was also used to determine the occupancy state of uPAR by measuring uPA on the cell surface relative to the quantity of uPA bound after prior treatment with HMW-uPA (1 g/ml for 15 min at 4°C). Immediately upon purifying the PMNs, 30.3 Ϯ 4.3% (mean Ϯ SEM; n ϭ 9) of available uPA binding sites were occupied with uPA. (27) . To provide another frame of reference for PMNs, fluo-3/AM-labeled PMNs were stimulated with FMLP (5 ϫ 10 Ϫ7 M), producing virtually immediate, large, and transient (Fig. 2B ). PMNs were also treated with high concentrations of HMW-uPA (4000 IU/ml, ϳ44 M) to compare the effects on Ca 2ϩ signaling of uPAR ligation vs uPAR aggregation. Similar to findings reported previously (22) , binding uPA to uPAR elicited increases in [Ca 2ϩ ] i (Fig. 3) . However, the response differed from that elicited by uPAR aggregation in several important respects. First, like FMLP, the onset of the response to HMW-uPA was virtually immediate, consistent with a simple ligand-receptor interaction. Secondly, the response was relatively brief. As shown by a representative tracing in Fig. 3A , there was an initial spike of 10 s or less, followed by a gradual return to baseline. The overall duration of the response was 63.3 Ϯ 4.1 s, which was one-half the duration of the [Ca 2ϩ ] i response to uPAR aggregation. The ⌬ [Ca 2ϩ ] i integrated over time indicates that the magnitude of the Ca 2ϩ signal to uPAR cross-linking exceeded the response to HMW-uPA ligation by Ͼ3-fold (Fig. 3B) . Stimulation with 2000 IU/ml HMW-uPA, although still far exceeding the 0.1-0.5 nM K d reported for uPAR (6), did not have a significant effect on [Ca 2ϩ ] i (not shown). To determine whether occupancy with uPA influences Ca 2ϩ signaling through uPAR, uPA-occupied uPAR were selectively crosslinked with an anti-uPA primary mAb. As shown in Fig. 4 ] i signal appears to be related to the quantity of uPAR cross-linked regardless of the state of occupancy with uPA.
Effect of uPAR aggregation on intracellular
Expression of adhesion molecules
Many routes of proinflammatory signaling induce PMNs to alter the expression of adhesion molecules so as to facilitate the transition from nonadherent or loosely adherent, rolling adhesion to firm, integrin-mediated adhesion. To determine whether signals initiated by uPAR can promptly alter expression of adhesion molecules, PMNs were subjected to uPAR cross-linking, after which the cells were immunolabeled with FITC-conjugated anti-CD11b, FITC-conjugated anti-L-selectin, or an isotype-matched (IgG1) control mAb. Cross-linking uPAR increased surface levels of CD11b by ϳ80%, with the maximal response occurring within 5 min (Fig. 5) . While cross-linking the control IgG2a mAb induced a smaller increase in CD11b expression, the response to uPAR cross-linking was significantly greater after both 5 and 10 min ( p Ͻ 0.02). Progressive loss of L-selectin was seen over 40 min even after cross-linking the control IgG2a mAb, possibly triggered by the repeated manipulations inherent in the cross-linking procedure. Cross-linking uPAR caused greater losses of L-selectin consistently throughout the time course, but the differences from control were not statistically significant. 
Effects of uPA-uPAR aggregation on neutrophil degranulation
To further examine the downstream consequences of uPAR aggregation, PMNs were subjected to the receptor aggregation protocols described above and incubated at 37°C for 10 min in the presence of cytochalasin B (5 g/ml) to enhance the release of intracellular granules (33) . Cells were preloaded with fluo-3/AM so the increase in [Ca 2ϩ ] i could be monitored in parallel. As shown in Fig. 6 , uPAR aggregation significantly increased the release of ␤-glucuronidase (a marker of azurophilic granules) and lactoferrin (a marker of specific granules). In both cases, degranulation was significantly greater than the response to cross-linking a control IgG2a mAb. Interestingly, the magnitude of both degranulation responses correlated very closely with the log of the concomitant ⌬ [Ca 2ϩ ] i (Fig. 6 ). Selectively aggregating uPA-uPAR complexes with the anti-uPA mAb produces minimal levels of degranulation, again in keeping with the smaller increases in [Ca 2ϩ ] i (Fig. 7) . However, preloading uPAR with exogenous HMW-uPA at 4°C before aggregating the uPA-uPAR complexes augmented the degranulation responses, virtually duplicating the effect of aggregating uPAR directly. Preloading with HMW-uPA followed by sham cross-linking (no primary mAb) did not induce degranulation (not shown). The effects of acutely exposing cells to high concentrations of HMW-uPA was determined by adding 4000 IU/ml to PMNs at 37°C and measuring degranulation over 10 min. HMWuPA triggered a modest degree of degranulation over unstimulated controls (3.7 Ϯ 2.1% ␤-glucuronidase release (mean Ϯ SEM; n ϭ 5; not significant) and 214.3 Ϯ 67.9 ng/ml lactoferrin release (mean Ϯ SEM; n ϭ 6; p Ͻ 0.03)). These findings indicate that both the magnitude of the [Ca 2ϩ ] i signal and the degranulation responses are dependent upon the extent to which uPAR is aggregated, and the occupancy state of uPAR with uPA has little or no impact on degranulation.
Modulation of PMN superoxide release
Freshly purified PMNs were treated to cross-link uPAR directly (3B10 anti-uPAR mAb, binding preferentially to unoccupied uPAR) or only uPA-uPAR complexes (using the anti-uPA mAb). Cells were then incubated 45 min to measure superoxide release. Experiments were also performed where cross-linking was initiated 30 min before adding FMLP, after which superoxide release was measured over 45 min. Neither saturating available uPAR with HMW-uPA (1 g/ml) nor uPAR aggregation with the 3B10 mAb had any direct effect on superoxide production (Fig. 8) . By contrast, selectively cross-linking uPA-uPAR complexes significantly increased superoxide release, approximately equivalent to a half-maximal response to FMLP. Moreover, the amount of uPA bound to uPAR, although occupying only 30% of the available binding sites, was sufficient to support this response fully, because superoxide release was not increased further by preloading uPAR with HMW-uPA before cross-linking. Aggregating uPA-uPAR complexes also increased the subsequent superoxide response to FMLP over a range of concentrations from 10 Ϫ9 -10 Ϫ6 M (Fig. 9 ). At the higher FMLP concentrations, the additive effect was approximately twice the increment in superoxide release induced by uPA/uPAR cross-linking alone. Again, saturating uPAR with uPA before cross-linking with the anti-uPA mAb did not magnify this effect. Directly cross-linking uPAR with the 3B10 mAb enhanced FMLP-induced superoxide release as well, but the effect was comparatively small (Fig. 9) . These findings indicate that aggregating uPA-uPAR complexes is capable of enhancing superoxide release both alone and as a costimulus with FMLP, while aggregating the receptor without its ligand cannot fully duplicate these responses.
Discussion
The mechanisms by which uPAR triggers activation signaling are only partly elucidated. In some cell types, uPAR is a component of large multiprotein complexes containing signaling intermediates such as Src and Jak tyrosine kinases (16 -21) . Structural characterization of uPAR has shown that it is a glycosylated single polypeptide linked to the plasma membrane by a GPI anchor (37) . Several GPI-anchored proteins are known to regulate cellular activation, adhesion, and migration (38) , even though GPI anchors only penetrate the outer leaflet of the plasma membrane and thus have no direct access to cytoplasmic signaling intermediates. The ability of uPAR to complex with membrane-spanning proteins has suggested that uPAR can initiate leukocyte activation by appropriating the signaling mechanisms of a partner protein such as CR3, in effect using it as a signal transduction device. It has been shown that cooperative signaling through uPAR and CR3 is required for exogenous uPA to generate an intracellular signal in human PMNs (22) . By contrast, the Ca 2ϩ signal induced by uPAR aggregation appears to be CR3 independent, although it remains to be determined what membrane-spanning partner proteins, if any, are necessary for this signaling pathway (27) . Membrane-spanning proteins associated with uPAR include the ␤ 2 integrins LFA-1, CR3, and CR4; ␤ 1 , ␤ 3 , and ␤ 5 integrins (9 -15, 39) ; and the mannose-6-phosphate/insulin-like growth factor II receptor (40) . Exogenous uPA or its uPAR-binding fragment can trigger phosphorylation of multiple ] i , and activate fos, jun, and myc oncogenes (18 -22, 27, 41-43) . Engaging uPAR by uPA binding or by cross-linking also activates Jak1 tyrosine kinase and nuclear translocation of Stat1 transcription regulatory factor (16, 17) . In some cell types, uPAR is found in or near caveolae, specialized structures of the plasma membrane where signaling molecules are congregated (44 -46) . In uPARtransfected epithelial cells, caveolin, a major constituent of caveolae, serves as an organizing protein for Src kinase activation (46) . It remains to be determined whether uPAR interacts with caveolin or functions within caveolae-like structures in leukocytes. The recently described coupling between uPAR and the mannose-6-phosphate/insulin-like growth factor II receptor may indirectly influence activation signaling under some circumstances by facilitating activation of latent TGF-␤1, but it is not known whether a direct pathway of cooperative signaling between these proteins exists (40) .
The present study demonstrates that uPAR, although expressed at relatively low levels in resting human PMNs, is capable, when aggregated, of initiating intracellular signaling, manifested by increased [Ca 2ϩ ] i . The response to uPAR aggregation was substantial, approximately one-half of the response elicited by FMLP (Figs. 1 and 2) , as reflected by the integrated Ca 2ϩ signal (area under the [Ca 2ϩ ] i vs time curve), which was used to contend with the distinctly different Ca 2ϩ waveforms generated by the two stimuli. Analyzing the results in this way, it is also apparent that uPAR aggregation induces a much larger Ca 2ϩ response than supersaturating concentrations of exogenous HMW-uPA. The magnitude of the increase in [Ca 2ϩ ] i also exceeds the responses to uPAR aggregation seen in U937 cells and monocytes (27) . Certainly, the consequences of Ca 2ϩ signaling cannot be judged only by the magnitude of the change in [Ca 2ϩ ] i . Further studies of individual cells using quantitative fluorescence microscopy will be necessary to determine not only the size but also the subcellular distribution and configuration (transient vs sustained or oscillatory) of the Ca 2ϩ responses, all factors that impact downstream activation signaling (47) .
The immediate effects of aggregating uPAR include significant up-regulation of CR3 expression (Fig. 5) , suggesting that uPAR aggregation may be a factor in the progression of PMNs toward firm, CR3-dependent adhesion. This transition is not uniquely elicited by uPAR cross-linking, as aggregating L-selectin and CR3 produce similar results (3) (4) (5) . Nevertheless, CR3 and L-selectin colocalize during L-selectin aggregation, just as uPAR can colocalize with CR3, so it possible that these activation schemes are all converging on shared signaling pathways rather than representing redundant, but independent, mechanisms of PMN activation (3, 14) .
As shown in Fig. 6 , uPAR aggregation elicits PMN degranulation, as represented by enhanced release of ␤-glucuronidase and lactoferrin (48) . The magnitude of the degranulation response was closely related to the magnitude of the increase in [Ca 2ϩ ] i , and neither was significantly affected by the state of receptor occupancy, i.e., the presence or the absence of associated uPA. Although few if any agonists can match the massive degranulation induced by FMLP, the magnitude of the degranulation response to uPAR aggregation was comparable to that described for PMN extravasating into a wound in vivo or to the responses in vitro to other proinflammatory agonists, such as leukotriene B4 and IL-8 (49 -51) . Because uPAR aggregation occurs as leukocytes adhere and migrate (7, 14) , it is reasonable to speculate that coordinating with granule release could enhance vascular permeability and matrix degradation, and thereby facilitate PMN extravasation. The role of intracellular Ca 2ϩ mobilization in triggering PMN degranulation remains controversial, but it appears that increased [Ca 2ϩ ] i is variably associated with degranulation depending on the agonist (52) . The close correlation between the two events in this study certainly implies that in the case of uPAR aggregation, they are proximate downstream events of a common pathway.
One of the more remarkable findings of this study was the enhanced superoxide release triggered specifically by aggregating uPA-uPAR complexes (Figs. 8 and 9 ). In many ways, this observation expands on the prior observations of Cao et al. (22) , who reported that HMW-uPA primes PMNs for superoxide release by forming a ternary signaling complex with uPAR and CR3. The present study shows that aggregating uPA circumvents the need for very high, and arguably supraphysiologic, concentrations of HMW-uPA needed to elicit this response. In fact, the relatively small proportion (ϳ30%) of uPAR occupied with uPA was fully capable of triggering a maximal response, as loading available uPAR with exogenous HMW-uPA did not enhance superoxide release (Figs. 8 and 9 ). Moreover, HMW-uPA, having no direct effect of its own, only enhanced FMLP-induced superoxide release (22) , while aggregating uPA-uPAR complexes directly increased superoxide release in addition to enhancing the effects of FLMP. Cooperative signaling between uPA-uPAR aggregation and FMLP produced somewhat more than additive superoxide responses, although the increase was not large enough to firmly conclude that the two stimuli are truly synergistic. It remains to be determined whether CR3 serves as the signal transduction device for uPAuPAR complexes in modulating superoxide release. This certainly is a plausible mechanism, because CR3 is involved in superoxide release (53) . However, the Ca 2ϩ signal elicited by uPAR aggregation appears to be independent of CR3 (27) , suggesting that uPAR may engage discrete signaling pathways depending upon the choice of signaling partner with which it associates. CR4 (CD11c/CD18; p150/95) is another candidate signaling partner for uPAR, because cytosolic NAD(P)H autofluorescence oscillations vary in synchrony, but out of phase, with proximity oscillations between aggregated uPAR and CR4 in polarized PMNs (12) . It is not known whether the association with CR4 diminishes the intrinsic ability of uPA-uPAR complexes to trigger superoxide release or displaces another partner protein from associating with uPA-uPAR. Regardless of the mechanisms involved, the present results indicate that aggregating uPA-uPAR complexes may contribute to enhanced oxidant-mediated tissue injury during PMN adhesion and migration. Moreover, it is clear that aggregation of uPAR initiates two distinct pathways of activation signaling, one being independent of receptor occupancy state and resulting in [Ca 2ϩ ] i mobilization and degranulation, and the other critically dependent on occupancy with uPA and resulting in enhanced superoxide release.
Prior work has emphasized the role that uPAR plays as an adapter protein that articulates its effects on cellular functions through its interactions with integrins. The present study has examined uPAR clustering as an isolated stimulus for proinflammatory signaling in nonadherent PMNs. However, one would expect that activation signaling initiated by uPAR aggregation in vivo would occur in adherent PMNs. It is not yet clear how uPAR clustering occurs in vivo, but it may occur actively as PMNs encounter a uPAR counterligand such as vitronectin (54) , or it may occur passively as integrins or other proteins capable of binding uPAR are drawn into a clustered configuration. In either case, the signaling pathways engaged by uPAR clustering may be coupled to complimentary chemokine and integrin-mediated signaling events, and it will be necessary to investigate the role of uPARmediated activation signaling in this context. FIGURE 8. Effects of uPAR cross-linking on superoxide release. Selectively cross-linking uPAR endogenously occupied with uPA (uPA-XL) or uPAR saturated with exogenous HMW-uPA (uPA ϩ uPA XL) both elicited a significant increase in superoxide release. By contrast, preferentially cross-linking unoccupied uPAR with the 3B10 mAb (uPAR XL) and saturating with HMW-uPA had no effect (significance determined by oneway ANOVA with Dunnett's post-test; mean Ϯ SEM; n ϭ 5; unstimulated controls, n ϭ 18).
FIGURE 9.
Selectively cross-linking uPAR endogenously occupied with uPA (unloaded uPA XL) or uPAR after treatment with a saturating concentration of HMW-uPA (Loaded uPA XL) significantly increases superoxide release in response to FMLP, added 30 min after the cross-linking Ab. By comparison, preferentially cross-linking unoccupied uPAR with the 3B10 mAb (uPAR XL) caused relatively small, but statistically significant, increases in superoxide release (significance determined by one-way ANOVA with Bonferroni's post-test; mean Ϯ SEM; n ϭ 4). ‫,ء‬ p Ͻ 0.01.
